Catalyst Wire Dossier Catalyst Wire Dossier

DAY101

tovorafenib · Day One Biopharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for DAY101, covering 2025-08-14 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) [Phase 3]

See pricing